赵春莉等

[摘要] 目的 探讨连续性静脉血滤(CVVH)在脓毒血症相关心衰患者中的疗效与安全性。方法 选取2010年3月—2013年3月该院重症医学科发生脓毒血症出现心衰的住院患者25例为研究组,所有患者均采用CVVH治疗模式,观察其血滤前后心功能及各项临床指标的变化,并与单纯应用药物治疗重症感染致心衰患者16例(对照组)作对比。比较两组患者治疗前后心脏功能的变化。 结果 研究组患者病死率低于对照组,研究组患者经持续静脉血滤治疗后心功能及感染症状等均明显改善(P<0.05),而对照组则变化不明显,甚至病情加重,差异有统计学意义。 结论 CVVH能够显著改善脓毒症相关性心衰患者心功能,疗效确切,无明显不良反应。
[关键词] 脓毒症;心衰;血滤;急性生理与慢性健康评分Ⅱ
[中图分类号] R655;R816.4 [文献标识码] A [文章编号] 1674-0742(2015)01(c)-0003-03
[Abstract] Objective To investigate the efficacy and safety of continuous venovenous hemofiltration(CVVH) therapy in the treatment of heart failure associated with sepsis. Methods Twenty-five hospitalized patients with sepsis complicated by heart failure in the ICU of our hospital from March 2010 to March 2013 were selected as the study group, and all of them were given CVVH treatment. The cardiac function and various clinical indexes of the study group before and after hemofiltration were observed. Sixteen patients with heart failure due to severe infection were selected as the control group and treated only by drugs. And the cardiac function before and after treatment was compared between the two groups. Results Compared with the control group, the patients in the study group had lower mortality. The cardiac function and symptoms of infection of the patients in the study group after CVVH treatment improved significantly(P<0.05), while those of the patients in the control group did not change significantly, or even worse. The differences between the two groups were statistically significant. Conclusion CVVH can remarkably improve the heart function of patients with heart failure associated with sepsis, and the effect is exact without significant side effects.
[Key words] Sepsis; Heart failure; Hemofiltration; APACHE-II
脓毒症是临床常见的危重症,常合并心脏功能抑制[1],并可导致多脏器功能衰竭。除了传统的治疗手段,应用CVVH治疗脓毒血症相关心衰的疗效逐渐获得肯定,不仅具有可用于床旁治疗的优势,而且能降低脓毒血症患者的炎症反应、调节免疫状态及维持血液动力学稳定、控制病情进展。该院2010年3月—2013年3月间应用CVVH治疗脓毒症相关性心衰取得了很好的效果,现报道如下。
1 资料与方法
1.1 一般资料
选取大连市友谊医院重症医学科收治的脓毒血症致心衰患者41例,心衰诊断标准按照2009 ACC/AHA成人慢性心力衰竭诊断治疗指南执行。所有患者均给予常规药物治疗,随机分组,25例同时行CVVH(治疗组),16例未行CVVH(对照组)。治疗组男16例,女9例,年龄39~80岁,平均59.5岁。对照组男11例,女5例,年龄36~82岁,平均60.2岁。原发病重症肺炎27例,重症胰腺炎3例,胆道感染6例,泌尿系感染5例。……